Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 5
- 0 vs. Q4 2022
- Portfolio value
- $175.0M
- −$9.37M (−5.1%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $94.3M | 53.9% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $41.3M | 23.6% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $30.5M | 17.4% | 00.0% | Unchanged | History |
| CELLBruker Cellular Analysis, Inc. | COM | 5,390,820 | $6.25M | 3.6% | +5,390,820 | New | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $2.61M | 1.5% | 00.0% | Unchanged | History |
Sold out since Q4 2022 (1)
Positions held at the end of Q4 2022 that are gone from this filing.